REG - Hikma Pharmaceutical - Director/PDMR Shareholding
RNS Number : 6668QHikma Pharmaceuticals Plc22 June 2020Hikma Pharmaceuticals PLC
Notification and public disclosure of transactions by persons discharging managerial responsibilities
Said Darwazah
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Said Darwazah
2
Reason for the notification
a)
Position/status
Executive Chairman
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Hikma Pharmaceuticals PLC
b)
LEI
549300BNS685UXH4JI75
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument and identification code
Description: Ordinary shares of 10 pence each
ID Code: GB00B0LCW083
b)
Nature of the transaction
Extension of existing pledge by Darhold Limited of 2,000,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in support of a loan, in favour of EFG Bank. Darhold Limited is defined as a Person Closely Associated with the Executive Chairman, who is a director and shareholder of Darhold.
c)
Price(s) and volume(s)
Price(s): £0.00p
Volume(s): 2,000,000
d)
Aggregated information
Aggregated volume: 2,000,000
Price: £0.00p
e)
Date of the transaction
22 June 2020
f)
Place of the transaction
Amman
Mazen Darwazah
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Mazen Darwazah
2
Reason for the notification
a)
Position/status
Executive Vice Chairman
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Hikma Pharmaceuticals PLC
b)
LEI
549300BNS685UXH4JI75
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument and identification code
Description: Ordinary shares of 10 pence each
ID Code: GB00B0LCW083
b)
Nature of the transaction
Extension of existing pledge by Darhold Limited of 2,000,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in support of a loan, in favour of EFG Bank. Darhold Limited is defined as a Person Closely Associated with the Executive Vice Chairman, who is a director and shareholder of Darhold.
c)
Price(s) and volume(s)
Price(s): £0.00p
Volume(s): 2,000,000
d)
Aggregated information
Aggregated volume: 2,000,000
Price: £0.00p
e)
Date of the transaction
22 June 2020
f)
Place of the transaction
Amman
Mohammed 'Ali' Al-Husry
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Mohammed 'Ali' Al-Husry
2
Reason for the notification
a)
Position/status
Non-Executive Director
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Hikma Pharmaceuticals PLC
b)
LEI
549300BNS685UXH4JI75
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument and identification code
Description: Ordinary shares of 10 pence each
ID Code: GB00B0LCW083
b)
Nature of the transaction
Extension of existing pledge by Darhold Limited of 2,000,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in support of a loan, in favour of EFG Bank. Darhold Limited is defined as a Person Closely Associated with the Non-Executive Director, who is a director and shareholder of Darhold.
c)
Price(s) and volume(s)
Price(s): £0.00p
Volume(s): 2,000,000
d)
Aggregated information
Aggregated volume: 2,000,000
Price: £0.00p
e)
Date of the transaction
22 June 2020
f)
Place of the transaction
Amman
Peter Speirs
Company Secretary, responsible for releasing this announcement
+44 (0) 20 7399 2760
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDDSHBGGDLCBDDGGD
Recent news on Hikma Pharmaceuticals
See all newsREG - Hikma Pharmaceutical - Result of AGM
AnnouncementREG - Hikma Pharmaceutical - Trading Statement
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Hikma appoints new President of Generics business
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
Announcement